Compound Research
SEMAX
Synthetic Regulatory Peptide
Available Research Quantities
10 mg
Overview
SEMAX is an ACTH-derived synthetic peptide investigated as a research tool for exploring neurotrophic and neuroprotective pathways within the central nervous system. Current research centers on its potential to modulate neuronal function, synaptic plasticity, and cognitive performance in preclinical models.
Compound Class
ACTH-derived synthetic peptide
Research Focus
Neurotrophic signaling · Neuroprotection · Cognitive research
Key Properties
Form
Lyophilized powder
Mechanism (under investigation)
Investigated for effects on neurotrophic and neurotransmitter-associated signaling pathways within the central nervous system.
Regulatory status
Not FDA-approved in the United States.
Regulatory & Safety Considerations
SEMAX is provided for research use only. It is not intended for human or veterinary use, diagnostic procedures, therapeutic applications, or consumption. Researchers are responsible for handling, storage, and disposal in accordance with institutional policies and applicable regulations.
Research Use Only. SEMAX is supplied exclusively for qualified laboratory research. Not for human use, clinical applications, or household purposes.